The Improvement in Symptoms After Sublingual Immunotherapy for Japanese Cedar Pollinosis Coincided With the Reduction in Nasal Metachromatic and Eosinophilic Cells

Background and objectivePreviously, it was reported that droplet SLIT in Japanese cedar pollinosis reduced metachromatic cell and eosinophil counts in nasal swabs along with symptom improvement. In this study, it was confirmed that SLIT using tablets also reduces the number of these cells along with symptom improvement, and examined the time course of these effects.MethodsOne hundred twenty-one visits of 57 subjects treated with SLIT occurred in our clinic between January 16 and April 8, 2023 (Jc pollen season). The 57 patients had been receiving SLIT for 0.16 to 7.8 yr, and symptoms were assessed using a self-reported questionnaire. Nasal swab cytology was used to compare the reduction in Mc, eosinophil and neutrophil numbers with that of non-SLIT 110 subjects. We then investigated the timelines of the decrease in Mc and eosinophils and their relationship to symptoms.ResultsC Subjects who received SLIT had significantly reduced moderate to most severe symptoms compared to non-SLIT subjects over the Jc pollen season. There was symptom improvement for subjects with ≤2 yr SLIT treatment, but more improvement after >2 yr of SLIT treatment. Mc and eosinophil numbers in nasal swabs of SLIT subjects were significantly lower than in non-SLIT subjects. Moreover, levels of eosinophilia decreased within 2 yr of SLIT treatment, but further decreased with >2 yr of SLIT. Mc numbers in subjects with >2 years of SLIT were significantly lower than in non-SLIT subjects. There was no significant difference in neutrophil numbers in nasal swabs between non-SLIT and SLIT subjects.ConclusionSLIT administered by tablet was effective in improving symptoms within 2 yr, and further improved after 2 yr. The eosinophil counts also decreased within 2 yr, and further decreased over 2 yr. The Mc count significantly decreased only after 2 yr of SLIT treatment.

Authors

Institutions

Publication Details

Journal
American Journal of Rhinology and Allergy
Published
2025-04-16
DOI
https://doi.org/10.1177/19458924251332768
Citations
1
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
1.62
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Improvement in Symptoms After Sublingual Immunotherapy for Japanese Cedar Pollinosis Coincided With the Reduction in Nasal Metachromatic and Eosinophilic Cells

Hirokuni Otsuka, Kimihiro Okubo, Shoji Matsune, Kuninori Otsuka
1 citations
American Journal of Rhinology and Allergy
Allergic Rhinitis and Sensitization
1.62
article

The Improvement in Symptoms After Sublingual Immunotherapy for Japanese Cedar Pollinosis Coincided With the Reduction in Nasal Metachromatic and Eosinophilic Cells

Hirokuni Otsuka, Kimihiro Okubo, Shoji Matsune, Kuninori Otsuka
article en
1 citations

Abstract

Background and objectivePreviously, it was reported that droplet SLIT in Japanese cedar pollinosis reduced metachromatic cell and eosinophil counts in nasal swabs along with symptom improvement. In this study, it was confirmed that SLIT using tablets also reduces the number of these cells along with symptom improvement, and examined the time course of these effects.MethodsOne hundred twenty-one visits of 57 subjects treated with SLIT occurred in our clinic between January 16 and April 8, 2023 (Jc pollen season). The 57 patients had been receiving SLIT for 0.16 to 7.8 yr, and symptoms were assessed using a self-reported questionnaire. Nasal swab cytology was used to compare the reduction in Mc, eosinophil and neutrophil numbers with that of non-SLIT 110 subjects. We then investigated the timelines of the decrease in Mc and eosinophils and their relationship to symptoms.ResultsC Subjects who received SLIT had significantly reduced moderate to most severe symptoms compared to non-SLIT subjects over the Jc pollen season. There was symptom improvement for subjects with ≤2 yr SLIT treatment, but more improvement after >2 yr of SLIT treatment. Mc and eosinophil numbers in nasal swabs of SLIT subjects were significantly lower than in non-SLIT subjects. Moreover, levels of eosinophilia decreased within 2 yr of SLIT treatment, but further decreased with >2 yr of SLIT. Mc numbers in subjects with >2 years of SLIT were significantly lower than in non-SLIT subjects. There was no significant difference in neutrophil numbers in nasal swabs between non-SLIT and SLIT subjects.ConclusionSLIT administered by tablet was effective in improving symptoms within 2 yr, and further improved after 2 yr. The eosinophil counts also decreased within 2 yr, and further decreased over 2 yr. The Mc count significantly decreased only after 2 yr of SLIT treatment.

American Journal of Rhinology and AllergyVol. 39(4)
Otsuka (Japan) (JP), JR Tokyo General Hospital (JP), Nippon Medical School (JP)
Good health and well-being
Openalex Percentile: Top 21%
Allergic Rhinitis and Sensitization
1.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.